Early Use of Remdesivir in Patients Hospitalized With COVID-19 Improves Clinical Outcomes: A Retrospective Observational Study

BACKGROUND: Remdesivir treatment, like most antiviral drugs, is likely to be most effective when used early in the course of coronavirus disease 2019 (COVID-19). Optimal timing of remdesivir for the treatment of COVID-19 remains unclear. OBJECTIVES: The aim of this study was to determine whether ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Paranjape, Neha, Husain, Mir, Priestley, Jennifer, Koonjah, Yashila, Watts, Christopher, Havlik, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436815/
https://www.ncbi.nlm.nih.gov/pubmed/34539162
http://dx.doi.org/10.1097/IPC.0000000000001023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436815/
https://www.ncbi.nlm.nih.gov/pubmed/34539162
http://dx.doi.org/10.1097/IPC.0000000000001023

Ejemplares similares